BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//BioCatalystFeed//bcf//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BioCatalystFeed VERX catalysts
X-WR-CALDESC:Scheduling/reference data from public records\; dates can move
 . Not investment\, legal or medical advice.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:c7d88258871a682d44e0@biocat.ai
DTSTAMP:20261118T181353Z
DTSTART;VALUE=DATE:20270125
DTEND;VALUE=DATE:20270126
SUMMARY:VERX P3 readout (est.): Evaluation of the Long-term Safety and Effe
 ctiveness of Suzetrigine (SUZ) in Participants With Painful Diabetic Perip
 heral Neuropathy (DPN)
DESCRIPTION:Evaluation of the Long-term Safety and Effectiveness of Suzetri
 gine (SUZ) in Participants With Painful Diabetic Peripheral Neuropathy (DP
 N)\nNCT06696443 | PHASE3 | ACTIVE_NOT_RECRUITING | sponsor: Vertex Pharmac
 euticals Incorporated\nPrimary completion date (ESTIMATED)\; top-line resu
 lts usually follow later.\nTicker VERX (confidence 0.9)\nSource: https://c
 linicaltrials.gov/study/NCT06696443\nScheduling/reference data from public
  records\; dates can move. Not investment\, legal or medical advice.
TRANSP:TRANSPARENT
URL:https://clinicaltrials.gov/study/NCT06696443
CATEGORIES:readout,ESTIMATED
END:VEVENT
BEGIN:VEVENT
UID:e5a2f26c8e246efd6128@biocat.ai
DTSTAMP:20261118T181353Z
DTSTART;VALUE=DATE:20270202
DTEND;VALUE=DATE:20270203
SUMMARY:VERX P1/P2 readout (est.): Galileo
DESCRIPTION:A Phase 1/2 Study of VX-670 in Adult Participants With Myotonic
  Dystrophy 1 (DM1)\nNCT06185764 | PHASE1/PHASE2 | ACTIVE_NOT_RECRUITING | 
 sponsor: Vertex Pharmaceuticals Incorporated\nPrimary completion date (EST
 IMATED)\; top-line results usually follow later.\nTicker VERX (confidence 
 0.9)\nSource: https://clinicaltrials.gov/study/NCT06185764\nScheduling/ref
 erence data from public records\; dates can move. Not investment\, legal o
 r medical advice.
TRANSP:TRANSPARENT
URL:https://clinicaltrials.gov/study/NCT06185764
CATEGORIES:readout,ESTIMATED
END:VEVENT
BEGIN:VEVENT
UID:2725ce0a3d5c1f47fcb5@biocat.ai
DTSTAMP:20261118T181353Z
DTSTART;VALUE=DATE:20260327
DTEND;VALUE=DATE:20260328
SUMMARY:VERX APPROVAL: TRIKAFTA (COPACKAGED)
DESCRIPTION:Approved 2026-03-27: TRIKAFTA (COPACKAGED) (NDA212273 SUPPL14)\
 nConfidence: confirmed\nTicker VERX (confidence 0.6)\nSource: https://www.
 accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplN
 o=212273\nScheduling/reference data from public records\; dates can move. 
 Not investment\, legal or medical advice.
TRANSP:TRANSPARENT
URL:https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overvie
 w.process&ApplNo=212273
CATEGORIES:approval,confirmed
END:VEVENT
BEGIN:VEVENT
UID:3204d517d3a3594cd664@biocat.ai
DTSTAMP:20261118T181353Z
DTSTART;VALUE=DATE:20260327
DTEND;VALUE=DATE:20260328
SUMMARY:VERX APPROVAL: ALYFTREK
DESCRIPTION:Approved 2026-03-27: ALYFTREK (NDA218730 SUPPL1)\nConfidence: c
 onfirmed\nTicker VERX (confidence 0.6)\nSource: https://www.accessdata.fda
 .gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218730\nSche
 duling/reference data from public records\; dates can move. Not investment
 \, legal or medical advice.
TRANSP:TRANSPARENT
URL:https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overvie
 w.process&ApplNo=218730
CATEGORIES:approval,confirmed
END:VEVENT
BEGIN:VEVENT
UID:02dce75f0c90f887d335@biocat.ai
DTSTAMP:20261118T181353Z
DTSTART;VALUE=DATE:20260327
DTEND;VALUE=DATE:20260328
SUMMARY:VERX APPROVAL: TRIKAFTA (COPACKAGED)
DESCRIPTION:Approved 2026-03-27: TRIKAFTA (COPACKAGED) (NDA217660 SUPPL8)\n
 Confidence: confirmed\nTicker VERX (confidence 0.6)\nSource: https://www.a
 ccessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo
 =217660\nScheduling/reference data from public records\; dates can move. N
 ot investment\, legal or medical advice.
TRANSP:TRANSPARENT
URL:https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overvie
 w.process&ApplNo=217660
CATEGORIES:approval,confirmed
END:VEVENT
END:VCALENDAR
